oxybutynin has been researched along with Beuren Syndrome in 3 studies
oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.
| Excerpt | Relevance | Reference |
|---|---|---|
| "6 mg/kg oxybutynin daily resulted in improvement of lower urinary tract symptoms, quality of life and maximum flow rate in most patients with Williams-Beuren syndrome." | 9.16 | The effects of oxybutynin on urinary symptoms in children with Williams-Beuren syndrome. ( Bruschini, H; de Bessa, J; Gomes, CM; Honjo, RS; Kim, CA; Pinheiro, MS; Sammour, ZM; Srougi, M; Trigo-Rocha, FE, 2012) |
| "6 mg/kg oxybutynin daily resulted in improvement of lower urinary tract symptoms, quality of life and maximum flow rate in most patients with Williams-Beuren syndrome." | 5.16 | The effects of oxybutynin on urinary symptoms in children with Williams-Beuren syndrome. ( Bruschini, H; de Bessa, J; Gomes, CM; Honjo, RS; Kim, CA; Pinheiro, MS; Sammour, ZM; Srougi, M; Trigo-Rocha, FE, 2012) |
| "Williams-Beuren syndrome is a chromosomal disorder caused by a deletion at region 7q11." | 1.62 | Longitudinal Improvement of Lower Urinary Tract Symptoms in Williams-Beuren Syndrome. ( Bruschini, H; de Bessa, J; Gomes, CM; Hisano, M; Nahas, WC; Sammour, ZM; Srougi, M, 2021) |
| "The Williams syndrome is a relatively rare disease with characteristic facial appearance, mental retardation, growth deficiency, cardiovascular anomalies, hypercalcemia and multiple organic dysfunctions." | 1.30 | [Neuro-urological findings in Williams syndrome: report of a case]. ( Borrelli Júnior, M; Borrelli, M; Freire, Gde C; Marinelli, CM; Sakuramoto, PK; Spinola, RT; Tobias-Machado, M, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Sammour, ZM | 2 |
| Hisano, M | 1 |
| de Bessa, J | 2 |
| Bruschini, H | 2 |
| Nahas, WC | 1 |
| Srougi, M | 2 |
| Gomes, CM | 2 |
| Pinheiro, MS | 1 |
| Kim, CA | 1 |
| Honjo, RS | 1 |
| Trigo-Rocha, FE | 1 |
| Tobias-Machado, M | 1 |
| Marinelli, CM | 1 |
| Sakuramoto, PK | 1 |
| Spinola, RT | 1 |
| Borrelli Júnior, M | 1 |
| Freire, Gde C | 1 |
| Borrelli, M | 1 |
1 trial available for oxybutynin and Beuren Syndrome
| Article | Year |
|---|---|
The effects of oxybutynin on urinary symptoms in children with Williams-Beuren syndrome.
Topics: Adolescent; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Hu | 2012 |
2 other studies available for oxybutynin and Beuren Syndrome
| Article | Year |
|---|---|
Longitudinal Improvement of Lower Urinary Tract Symptoms in Williams-Beuren Syndrome.
Topics: Adolescent; Adrenergic alpha-1 Receptor Antagonists; Child; Doxazosin; Female; Follow-Up Studies; Hu | 2021 |
[Neuro-urological findings in Williams syndrome: report of a case].
Topics: Child; Female; Humans; Mandelic Acids; Urinary Incontinence; Williams Syndrome | 1998 |